HALB News Alert Halberd Corporation (HALB) 0.0110 09/19/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Halberd Corporation (HALB) 0.0110 $HALB

I-TAP, Inc. to Conduct Test Installation for Legends
Marketwire - Thu Sep 18, 7:23AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. has secured a test installation of the I-TAP beer dispensing system for Legends.

I-TAP, Inc. Receives Order From TD Garden, Home of the Boston Bruins and Celtics
Marketwire - Tue Sep 16, 7:40AM CDT
Halberd Corporation (PINKSHEETS: HALB) subsidiary I-TAP, Inc. announced that the company has received a purchase order from the Delaware North Companies for the installation of I-TAP's proprietary electronic draft beer dispensing systems at TD Garden in Boston, home of the Boston Bruins and Celtics.

Halberd Corporation Signs Definitive Agreement With I-TAP, Inc.
Marketwire - Mon Sep 15, 7:05AM CDT
Halberd Corporation (PINKSHEETS: HALB) executed a definitive agreement and has acquired control of Sarasota, Florida based I-TAP, Inc.

Halberd Corporation Enters Into Binding Term Sheet to Acquire Control of I-TAP, Inc.
Marketwire - Thu Sep 11, 7:30AM CDT
Halberd Corporation (PINKSHEETS: HALB) entered into a binding term sheet this week to enter into a definitive agreement to acquire control of Sarasota, Florida based I-TAP, Inc. The definitive agreement is expected to be signed in the next two weeks.

Halberd Corporation's New Subsidiary Aspyre.com Discusses Revenue Streams
PR Newswire - Tue Jul 22, 8:14AM CDT
Halberd Corporation (OTC Market: HALB) subsidiary Aspyre.com discusses the Company revenue sources.

Halberd Corporation Responds To False Press Release Issued By SMSW Corporation
PR Newswire - Tue Jul 08, 9:55AM CDT
Halberd Corporation (OTC Market: HALB) Halberd Corporation responds to the false press release issued by the plaintiffs (in three separate causes of action), including Marvin Katz and his companies, and Stephen Wilshinsky, his company and his mother. As a part of these plaintiffs' misleading financial claims, they are suing Halberd Corporation and the defendants for refusing to violate the law. Despite the plaintiffs' false claims, there has been no determination of liability. Indeed, the plaintiffs have lost every single motion in these cases which has a ruling. The California cases are as follows: CV 13-01412 BRO and 2:12-cv-10041 FMO (FFMx); the Nevada Case No. is A-14-697936-P. Each suit is frivolous. And Halberd Corporation will continue to vigorously defend each suit.

Emphysema - Pipeline Review, H2 2013 Research Report
M2 - Fri Feb 14, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/5thttd/emphysema) has announced the addition of the "Emphysema - Pipeline Review, H2 2013" report to their offering. 'Emphysema - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Emphysema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Emphysema. Scope - A snapshot of the global therapeutic scenario for Emphysema. - A review of the Emphysema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Emphysema pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Emphysema Overview Therapeutics Development Emphysema - Pipeline Products Glance Clinical Stage Products Early Stage Products Unknown Stage Products Icure Pharmaceutical Inc. Emphysema - Therapeutics Assessment Drug Profiles Alpha 1-Proteinase Inhibitor - Drug Profile HI-164OV - Drug Profile Lysine Acetylsalicylate - Drug Profile Alpha-1 Antitrypsin With rHuPH20 - Drug Profile Drug For Emphysema - Drug Profile Retinoic Acid Receptor Agonists - Drug Profile formoterol fumarate Patch - Drug Profile Featured News & Press Releases Companies Mentioned Protalix BioTherapeutics, Inc. Bioxyne Limited Kamada Ltd. Intrexon Corporation Medestea Research & Production S.p.A. Northern Therapeutics, Inc. Icure Pharmaceutical Inc. For more information visit http://www.researchandmarkets.com/research/5thttd/emphysema About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Halberd Corporation Announces Intended Submission of US Government Bid for Wayfinding Kiosks
Marketwire - Wed Aug 07, 7:31AM CDT
Halberd Corporation (PINKSHEETS: HALB) is currently submitting a bid in a full and open competition to procure a US Government contract for an Interactive Wayfinding System that will incorporate Halberd's existing GPS technology at Fort Sam Houston in Houston, TX. Halberd will be constructing and implementing six custom built Wayfinding Kiosks along with interactive GPS software. Halberd will also be required to update the Wayfinding GPS software on a monthly basis along with providing training for the intended users at the Brooke Army Medical Center in Houston, TX.

Halberd Corporation Appoints New Hire
Marketwire - Mon Aug 05, 7:30AM CDT
Halberd Corporation (PINKSHEETS: HALB) announces the hire of Mr. Maurice Sanders. Mr. Sanders comes to Halberd with an extensive background in the computer sciences field and has an impressive work history for almost two decades, including serving four years in the United States Marine Corps.

Halberd Corporation Announces Submission of Source for $7.0M U.S. Government Contract
Marketwire - Thu Jul 25, 7:45AM CDT
Halberd Corporation (PINKSHEETS: HALB) is currently submitting credentials to procure $7.0M US Government contract for application of a Permetherin pesticide mixture to 800+ spruce/pine trees controlling the Epis/pine beetle, located at The Cheyenne VA Medical Center (VAMC). Halberd will utilize a scaled and modified gasoline engine unmanned aircraft system to allow spray calculations, time frame and distance for precision spray application of the Permetherin pesticide mixture. Halberd's UAVs will allow precision spray strokes to cover 100% of trunk circumference until runoff occurs helping minimize waste and potential ground contamination issues.

Halberd Corporation Announces New Commercial Property Search
Marketwire - Mon Jul 22, 3:15PM CDT
Halberd Corporation (PINKSHEETS: HALB) is actively and aggressively seeking out a new office and R&D location for further expansion. In addition to the office and R&D search, Halberd has a variety of highly trained personnel ready to be implemented. With this new location, Halberd will be increasing the sales team along with computer technician personnel who will be trained thoroughly in Halberd's unique unmanned aircraft systems. It's important that Halberd's sales and computer technician teams are knowledgable in the systems they are marketing as well as creating new ideas to improve on existing technology. The goal is for everyone to work together as one, to have Halberd run smoothly and effectively on a daily basis.

Halberd Corporation Announcement for Employment Contract Negotiations
Marketwire - Mon Jul 15, 7:01AM CDT
Halberd Corporation (PINKSHEETS: HALB) is currently in contract negotiations for a Product Development Research position. The prospect has fourteen years experience with the U.S. military, leading and training military personnel in both, Joint Terminal Attach Control and Combat Search and Rescue maneuvers. The prospect has unique specialized training in Remote Pilot Aircraft and Sensor Operations Equipment tactics. We are confident with this new hire, along with other specialized positions, that this strategic move will bring Halberd Corporation to the next level in creative development with our Unmanned Aircraft Systems.

Halberd Corporation Announces New Product Run
Marketwire - Thu Jul 11, 3:15PM CDT
Halberd Corporation (PINKSHEETS: HALB) has engaged in a limited production run of its Coroplast airframe models. These models will be covered in an ultra-light decal material giving the airframe an appearance of being the American Bald Eagle form. The models will be introduced at various air shows throughout the country in conjunction with existing product line demonstrations as a part of the new sales marketing campaign.

Halberd Corporation Announcement Entry Into the Online Consumer Market
M2 - Wed Jun 05, 1:53PM CDT
Company's Low Cost Unmanned Aircraft System Will Be Sold Online Through eBay, RC Universe and Other Online Retailers

Halberd Corporation Appoints New President
M2 - Thu May 30, 8:27AM CDT
LAS VEGAS, NV, May 30, 2013 -- Halberd Corporation (PINKSHEETS: HALB) would like to announce that, effective May 4, 2013, Stacie Allen has accepted the position of President for Halberd Corporation, after Reuben Lowing's termination.

Halberd Corporation Opens Sales and Marketing Location That Also Includes Research and Development Capabilities
Marketwire - Thu Feb 28, 8:30AM CST
Halberd Corporation (PINKSHEETS: HALB) is happy to announce it is opening a new sales and marketing office in Las Vegas. This office will serve as the new corporate headquarters and will combine the sales and marketing staff in one location. In addition to the sales and marketing offices there is expanded room for research and development as well as limited production. Nevada has a superior climate for testing and development of new unmanned systems. The additional flight days allow for shorter development time.

Halberd Corporation Signs Manufacturing Contract
Marketwire - Thu Feb 21, 9:30AM CST
Halberd Corporation (PINKSHEETS: HALB) announces they have entered into an exclusive manufacturing, marketing and distribution contract with Gevers Aircraft Company. The unique patented design of the 'triphibious' airframe gives this high performance aircraft the ability to take off and land on snow, water and land (http://halberdcorp.com/gevers.html). Halberd has additional uses in mind for this airframe that we will elaborate on in the future, but are currently being sought after by various branches of the military. The multipurpose landing gear, telescopic wings and interconnected propeller system provide increased utility, performance, and safety. President Reuben Lowing commented that "As a former Navy Seal I see numerous advantages for this unique configuration as it affords operation on snow, water and land. The US military, especially the Navy Seals will find these abilities superior to our competition. I expect products like this to continue to set us apart from our industry competitors. With our c

Halberd UAS Featured at Alaska Air Carriers Association Symposium
Marketwire - Fri Feb 08, 7:30AM CST
Halberd Corporation (PINKSHEETS: HALB) -- As a result of Halberd Corporation's partnership with the Unmanned Vehicle University we are proud to announce the delivery of its Shadow series airframe on February 13th to UVU, this airframe retails for $14,999.00. This airframe will be showcased at the Alaska Air Carriers Association Symposium in Anchorage, Alaska. The FAA has indicated that Alaska will be the first state approved for commercial UAS systems. UVU in 2012 had 150 students enrolled in the University's Master's and Doctorate programs. Halberd will shortly begin to deliver airframes for their estimated 2013 enrollment of 200 students. Courses from Unmanned Systems Engineering to Unmanned Autonomous Systems will use the Shadow for training and hands on practical use applications. The Shadow series was designed specifically for testing and development of all technologies on a robust and inexpensive airframe without putting at risk expensive airframes.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Del Monte's Sustainability Report Shows Significant Progress

Updated Category News Views 200

Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...

Continue Reading
MEXC Enhances User Security with New Compliance Measures

Updated Category News Views 118

MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...

Continue Reading
Market Insights: Asian Shares and Economic Influences

Updated Category News Views 154

Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...

Continue Reading
Understanding Recent CPSC Recalls and Safety Measures

Updated Category News Views 280

Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...

Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus

Updated Category News Views 213

Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...

Continue Reading